Current Oncology (Apr 2021)

Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic

  • Christopher J. L. Stone,
  • Ana P. Johnson,
  • Danielle Robinson,
  • Andriy Katyukha,
  • Rylan Egan,
  • Sophia Linton,
  • Christopher Parker,
  • Andrew Robinson,
  • Geneviève C. Digby

DOI
https://doi.org/10.3390/curroncol28030157
Journal volume & issue
Vol. 28, no. 3
pp. 1681 – 1695

Abstract

Read online

Background: Lung cancer (LC) care is resource and cost intensive. We launched a Multidisciplinary LC Clinic (MDC), where patients with a new LC diagnosis received concurrent oncology consultation, resulting in improved time to LC assessment and treatment. Here, we evaluate the impact of MDC on health resource utilization, patient and caregiver costs, and secondary patient benefits. Methods: We retrospectively analyzed patients in a rapid assessment clinic with a new LC diagnosis pre-MDC (September 2016–February 2017) and post-MDC implementation (February 2017–December 2018). Data are reported as means; unpaired t-tests and ANOVA were used to assess for significance. We also conducted a cost analysis. Resource utilization, out-of-pocket costs, procedure-related costs, and indirect costs were evaluated from the societal perspective and presented in 2019 Canadian dollars (CAD); multi-way worst/best case and threshold sensitivity analyses were conducted. Results: We reviewed 428 patients (78 traditional model, 350 MDC). Patients in the MDC model required significantly fewer oncology visits from LC diagnosis to first LC treatment (1.62 vs. 2.68, p p = 0.18) or staging investigations/patient (2.24 traditional vs. 2.02 MDC, p = 0.20). Post-MDC, there was an increase in invasive mediastinal staging for patients with stage 2/3 LC (15.0% vs. 60.0%, p Conclusions: An MDC led to a reduction in patient visits and direct patient and caregiver costs.

Keywords